材料科学
胶束
纳米医学
光动力疗法
PEG比率
体内
生物物理学
纳米技术
紫杉醇
体内分布
生物相容性
纳米颗粒
组合化学
体外
癌症
生物化学
有机化学
医学
化学
冶金
水溶液
经济
生物技术
内科学
生物
财务
作者
Rui Liu,Meinan Yu,Xiaotong Yang,Channakeshava Sokke Umeshappa,Chuan Hu,Wenqi Yu,Lin Qin,Yuan Huang,Huile Gao
标识
DOI:10.1002/adfm.201808462
摘要
Abstract Although nanoparticles are expected to revolutionize cancer treatment, their low efficacy remains the greatest limiting factor. Recent investigations found that nanoparticles' golden principle, the enhanced permeability and retention (EPR) effect, is limited by the complicated tumor microenvironment. Herein, novel transformable nanomaterials are designed to utilize the EPR effect more effectively. By tandem conjugation of the hydrophobic head (chlorin e6 (Ce6) or bilirubin (BR)), peptide to form hydrogen bond (Phe‐Phe‐Val‐Leu‐Lys (FFVLK)), and hydrophilic tail (polyethylene glycol (PEG)), chimeric molecules that can form micelles (Ce6/BR‐FFVLK‐PEG) in aqueous solution are synthesized. Notably, the spherical micelles retain shape transformability. After circulation and distribution, they respond to 650 nm laser irradiation, and morphologically change into nanofibers so as to facilitate their retention markedly inside the tumor. Upon loading a reactive oxygen species‐responsive paclitaxel dimer with thioketal linker (PTX 2 ‐TK), the resultant PTX 2 ‐TK@Ce6/BR‐FFVLK‐PEG nanomedicine serves as a potent chemo‐photodynamic therapeutic for cancer treatment. Evaluations at both cell level and animal level reveal that PTX 2 ‐TK@Ce6/BR‐FFVLK‐PEG exhibits superior biocompatibility and biodistribution, and suppresses 82.6% of in vitro cell growth and 61.8% of in vivo tumor growth at a common dose of intravenous injection (10 mg kg −1 PTX and 3.3 mg kg −1 Ce6), becoming a novel nanomedicine with extraordinary potential in cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI